Table 3 Average daily inhalation of Symbicort Turbuhaler and Seretide Diskus in patients with asthma
From: Pitfalls associated with the therapeutic reference pricing practice of asthma medication
High dose therapy | Medium dose therapy | |||||||
|---|---|---|---|---|---|---|---|---|
Male | Female | Male | Female | |||||
Age (years) | Seretide | Symbicort | Seretide | Symbicort | Seretide | Symbicort | Seretide | Symbicort |
18-30 | 1.38 | 1.28 | 1.36 | 1.19 | 1.30 | 1.90 | 1.95 | 1.74 |
31-40 | 1.34 | 1.97 | 1.28 | 1.47 | 1.36 | 1.97 | 1.32 | 1.78 |
41-50 | 1.61 | 1.62 | 1.34 | 1.48 | 1.33 | 2.07 | 1.36 | 2.03 |
51-60 | 1.46 | 1.66 | 1.37 | 1.56 | 1.39 | 2.40 | 1.33 | 2.22 |
61-70 | 1.51 | 1.87 | 1.47 | 1.67 | 1.44 | 2.38 | 1.42 | 2.27 |
>70 | 1.50 | 1.67 | 1.42 | 1.73 | 1.48 | 2.49 | 1.43 | 2.31 |